Treatment Overview: Fotona StarWalker is an FDA-cleared multi-wavelength laser workstation integrating Q-switched Nd:YAG (1064 nm) and Q-switched KTP (532 nm) wavelengths powered by Adaptive Structured Pulse (ASP) technology. Administered under the clinical supervision of Prof. Dr. Ismail Kucuker at our Istanbul clinic, it combines high-energy nanosecond pulses with picosecond peak acoustic shockwaves. This targeted photoacoustic action fragments resistant epidermal and dermal pigmentation—such as melasma, sun spots, and post-inflammatory dyschromia—while inducing deep neocollagenesis with zero thermal collateral damage.
Fotona StarWalker sets a clinical benchmark in dermatological laser applications through its proprietary Third Generation ASP (Adaptive Structured Pulse) technology.
By bridging ultra-short picosecond acoustic peaks with energy-rich nanosecond pulse widths, the system targets cutaneous chromophores with surgical precision.
Plastic, Reconstructive, and Aesthetic Surgery Specialist Prof. Dr. Ismail Kucuker configures targeted pulse dynamics at our Istanbul clinic, clearing pigmented lesions and stimulating collagen renewal while protecting healthy epidermal barriers.

Thanks to dual-wavelength versatility and modal flexibility (ranging from MaQX to VERSA3 and FRAC3 modes), StarWalker provides tailored therapeutic protocols:
Conventional single-pulse Q-switched lasers often rely on high photothermal heat, which can increase the risk of rebound hyperpigmentation in reactive skin types.
The StarWalker platform circumvents this via ASP technology, shaping pulses to produce mechanical photoacoustic pressure waves. These shockwaves break down dense pigment clusters into microscopic fragments that are cleared by macrophage phagocytosis, preserving neighboring cells.
At our Istanbul clinic, each Fotona StarWalker treatment follows a structured medical framework: